A 52-year-old woman from Delhi presents with a 6-week history of postmenopausal bleeding and lower abdominal pain. On examination, a fixed pelvic mass is palpable. Serum CA-125 is 420 U/mL. MRI pelvis shows a 7 cm solid ovarian mass with invasion into the bladder dome and rectosigmoid colon. Staging laparoscopy reveals Stage IVA disease (local invasion). She has good performance status (ECOG 0). What is the most appropriate management?

Explanation

## Diagnosis & Stage Assessment **Key Point:** Stage IVA ovarian cancer is defined by pleural effusion with positive cytology OR invasion of adjacent organs (bladder, colon, rectum) without distant parenchymal metastases. This patient has locally advanced disease with good performance status (ECOG 0)—making her a strong candidate for aggressive primary surgical management. ## Rationale for Primary Debulking Surgery with En Bloc Resection **High-Yield:** In Stage IVA ovarian cancer with organ invasion and ECOG 0–1, **primary debulking surgery (PDS) with en bloc resection** of invaded organs is the standard of care when: - Performance status is good (ECOG 0–1) - Invasion is limited to adjacent pelvic organs (bladder dome, rectosigmoid) — not extensive peritoneal carcinomatosis or distant metastases - An experienced gynecologic oncologist assesses that **R0 or R1 cytoreduction is achievable** Survival is significantly improved with complete cytoreduction (R0) compared to incomplete debulking or chemotherapy alone. En bloc resection involves removing the tumor together with the invaded organ segment (partial cystectomy for bladder dome invasion; segmental colectomy with primary anastomosis for rectosigmoid invasion) as a single specimen to maintain oncologic margins. **Clinical Pearl — When to choose NACT instead of PDS in Stage IVA:** - ECOG performance status ≥2 - Extensive peritoneal carcinomatosis (upper abdominal disease, diaphragmatic involvement) making R0 unlikely - Surgeon/multidisciplinary team assessment of unresectability at staging laparoscopy - Significant comorbidities precluding major surgery In this vignette, the patient has ECOG 0, invasion limited to bladder dome and rectosigmoid (resectable organs), and staging laparoscopy confirms Stage IVA — all favoring PDS. ## Why the Other Options Are Incorrect | Option | Reason Incorrect | |--------|-----------------| | B) Radiation then delayed surgery | Radiation is not standard first-line for ovarian cancer; no role in this setting | | C) Palliative chemotherapy alone | Inappropriate for ECOG 0 patient with potentially resectable Stage IVA disease; suboptimal survival | | D) NACT → pelvic exenteration | NACT is reserved for unresectable/high-risk cases; pelvic exenteration (total removal of pelvic organs) is far more morbid than en bloc resection and not indicated here when limited organ invasion is present | ## Stage IVA vs IVB Management | Feature | Stage IVA (Local Invasion / Pleural Effusion+) | Stage IVB (Distant Metastases) | |---------|-----------------------------------------------|-------------------------------| | Surgery approach | PDS with en bloc resection (if ECOG 0–1, resectable) | NACT first (unless minimal disease) | | En bloc resection | Indicated for limited adjacent organ invasion | Rarely indicated | | Median OS with R0 resection | 40–50 months | 20–30 months | **Key Point:** The distinction between PDS and NACT in Stage IVA hinges on resectability and performance status — not stage alone. This patient's ECOG 0 and limited invasion make PDS the optimal choice. [cite: NCCN Ovarian Cancer Guidelines v3.2023; FIGO 2023 Staging; Berek & Hacker's Gynecologic Oncology 6e Ch 11; Chi DS et al., J Clin Oncol 2015]